Chargement en cours...
Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis
Immune/inflammatory cells act in rheumatoid arthritis (RA)-affected patients by synthesizing several inflammatory mediators, including cytokines that initiate intracellular signaling. Recently, small molecule inhibitors of transduction and transcription signals that influence the intracellular pathw...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3890964/ https://ncbi.nlm.nih.gov/pubmed/24453498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JIR.S35901 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|